Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Obesity 1Non-alcoholic Fatty Liver Disease 1

Interventions

Metformin 9Liraglutide 3Exercise 3semaglutide 2Tirzepatide 2Nutrition Assessment 2Lidocaine 2Injections 2Docosahexaenoic Acids 2Diet 2sibutramine 1polyethylene glycol 3350 1oxycodone-acetaminophen 1naloxegol 1naldemedine 1methylnaltrexone 1Ursodeoxycholic Acid 1Tramadol 1Topiramate 1Solutions 1Sennosides 1Resistance Training 1Quality of Life 1Propofol 1Progestins 1Polyethylene Glycols 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Ursodeoxycholic Acid × Other × Clear all
NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Ain Shams University

Phase 4 Active not recruiting
200 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡